Relationships among participant international prostate symptom score, benign prostatic hyperplasia impact index changes and global ratings of change in a trial of phytotherapy in men with lower urinary tract symptoms

Journal of Urology

Volumn 189, Issue 3, 2013, Pages 987-992

  Barry, Michael J ^a   Cantor, Alan ^b   Roehrborn, Claus G ^c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

health status index; lower urinary tract symptoms; prostate; prostatic hyperplasia; psychometrics

Indexed keywords

PLACEBO; SABAL EXTRACT;

ADULT; AMERICAN UROLOGICAL ASSOCIATION SYMPTOM INDEX; ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; FOLLOW UP; HUMAN; INTERNATIONAL PROSTATE SYMPTOM SCORE; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHYTOTHERAPY; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; URINE FLOW RATE;

HUMANS; LOWER URINARY TRACT SYMPTOMS; MALE; MIDDLE AGED; PHYTOTHERAPY; PLANT PREPARATIONS; PROSTATIC HYPERPLASIA; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; URINATION;

EID: 84873703889     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2012.08.257     Document Type: Article

References (12)

1. J.Q. Clemens, T.W. Markossian, R.T. Meenan Overlap of voiding symptoms, storage symptoms, and pain in men and women J Urol 178 2007 1354
2. M.J. Barry, C.L. Link, M.F. McNaughton Collins Overlap of different urologic symptom complexes in a racially and ethnically diverse community-based population of men and women BJU Int 101 2007 45
3. K.S. Coyne, C.C. Sexton, Z. Kopp Assessing patients' descriptions of lower urinary tract symptoms (LUTS) and perspectives on treatment outcomes: results of qualitative research Int J Clin Pract 64 2010 1260
4. M.J. Barry, F.J. Fowler, M.P. O'Leary The American Urological Association symptom index for benign prostatic hyperplasia J Urol 148 1992 1549
5. M.J. Barry, P.J. Fowler, M.P. O'Leary Measuring disease-specific health status in men with benign prostatic hyperplasia Med Care 4 suppl. 1995 AS145
6. M.J. Barry, J. Adolfsson, J.E. Batista Measuring symptoms and health impact of benign prostatic hyperplasia and its treatments L. Denis, K. Griffiths, S. Khoury, Fourth International Consultation on BPH 1998 Plymbridge Plymouth, United Kingdom 265 321
7. M.P. O'Leary, J.T. Wei, C.G. Roehrborn Correlation of the International Prostate Symptom Score bother question with the Benign Prostatic Hyperplasia Impact Index in a clinical practice setting BJU Int 101 2008 1531
8. M.J. Barry, W.O. Williford, Y. Chang BPH-specific health status measures in clinical research: how much change in the AUA symptom index and the BPH impact index is perceptible to patients? J Urol 154 1995 1770
9. M.J. Barry, S. Meleth, J.Y. Lee Effect of increasing doses of saw palmetto extract on lower urinary tract symptoms: a randomized trial JAMA 306 2012 1344
10. J. Barkin, C. Roehrborn, P. Siami Effect of dutasteride, tamsulosin, and the combination on patient-reported quality of life and treatment satisfaction in men with moderate-to-severe benign prostatic hyperplasia: 2-year data from the CombAT trial BJU Int 103 2009 919
11. M.J. Barry, A.L. Avins, S. Meleth Performance of the American Urological Association symptom index with and without an additional urge incontinence item Urology 78 2011 550
12. C.G. Roehrborn, T.H. Wilson, L.K. Black Quantifying the contribution of symptom improvement to satisfaction of men with moderate to severe benign prostatic hyperplasia: 4-year data from the CombAT trial J Urol 187 2012 1732